Free Trial

Belite Bio Q1 2023 Earnings Report

Belite Bio logo
$58.22 +2.01 (+3.58%)
As of 01/21/2025 04:00 PM Eastern

Belite Bio EPS Results

Actual EPS
-$0.33
Consensus EPS
-$0.17
Beat/Miss
Missed by -$0.16
One Year Ago EPS
N/A

Belite Bio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Belite Bio Announcement Details

Quarter
Q1 2023
Time
N/A

Belite Bio Earnings Headlines

Breakeven On The Horizon For Belite Bio, Inc (NASDAQ:BLTE)
Trump currency shock imminent
Trump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.
Belite Bio (NASDAQ:BLTE) Stock Price Up 5.4% - Here's Why
Belite Bio: Interesting Science, But Quite A Few Worries
See More Belite Bio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Belite Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Belite Bio and other key companies, straight to your email.

About Belite Bio

Belite Bio (NASDAQ:BLTE), a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.

View Belite Bio Profile

More Earnings Resources from MarketBeat